Evidence map›Paper›PMID 32307268›Full record

ArticleJournal of integrative medicine2020

Active constituents and mechanisms of Respiratory Detox Shot, a traditional Chinese medicine prescription, for COVID-19 control and prevention: Network-molecular docking-LC-MS

Zi-Jia Zhang, Wen-Yong Wu, Jin-Jun Hou, Lin-Lin Zhang, Fei-Fei Li, Lei Gao, Xing-Dong Wu, Jing-Ying Shi, Rong Zhang, Hua-Li Long and 6 more

Open access · greenAbstract read
In one paragraph

Article in Journal of integrative medicine, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed
9.0field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 55 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Review
  5. A Brief Review on Medicinal Plants-At-Arms against COVID-19.Interdisciplinary perspectives on infectious diseases · 2023
    Review
  6. Review
  7. Review
  8. Article
  9. Article
  10. Anti-colon Cancer Effects ofFrontiers in medicine · 2022
    Article
  11. Review
  12. Pathomechanisms, therapeutic targets and potent inhibitors of some beta-coronaviruses from bench-to-bedside.Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases · 2021
    Review
  13. Article
  14. The direct evidence and mechanism of traditional Chinese medicine treatment of COVID-19.Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie · 2021
    Review
  15. Article
  16. Review
  17. Review
  18. Recent progress in the development of potential drugs against SARS-CoV-2.Current research in pharmacology and drug discovery · 2021
    Review
  19. Estimation of drug-likeness properties of GC-MS separated bioactive compounds in rare medicinalNetwork modeling and analysis in health informatics and bioinformatics · 2021
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 3 institutions in 1 country.

Zi-Jia ZhangShanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai 201203, China.
Wen-Yong WuShanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai 201203, China; University of Chinese Academy of Sciences, Beijing 100049, China.
Jin-Jun HouShanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai 201203, China.
Lin-Lin ZhangShanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai 201203, China.
Fei-Fei LiShanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai 201203, China; University of Chinese Academy of Sciences, Beijing 100049, China.
Lei GaoShanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai 201203, China; University of Chinese Academy of Sciences, Beijing 100049, China.
Xing-Dong WuShanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai 201203, China.
Jing-Ying ShiShanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai 201203, China; University of Chinese Academy of Sciences, Beijing 100049, China.
Rong ZhangShanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai 201203, China; University of Chinese Academy of Sciences, Beijing 100049, China.
Hua-Li LongShanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai 201203, China.
Min LeiShanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai 201203, China.
Wan-Ying WuShanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai 201203, China. Electronic address: wanyingwu@simm.ac.cn.
De-An GuoShanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai 201203, China. Electronic address: daguo@simm.ac.cn.
Kai-Xian ChenShanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai 201203, China. Electronic address: kxchen@simm.ac.cn.
Lewis A HofmannWorld Health Science Organization, Leesburg, VA 20176, USA.
Zhong-Hua CiWorld Health Science Organization, Leesburg, VA 20176, USA.
Chinese Academy of Sciences · CNShanghai Institute of Materia Medica · CNUniversity of Chinese Academy of Sciences · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveLung-toxin Dispelling Formula No. 1, referred to as Respiratory Detox Shot (RDS), was developed based on a classical prescription of traditional Chinese medicine (TCM) and the theoretical understanding of herbal properties within TCM. Therapeutic benefits of using RDS for both disease control and prevention, in the effort to contain the coronavirus disease 2019 (COVID-19), have been shown. However, the biochemically active constituents of RDS and their mechanisms of action are still unclear. The goal of the present study is to clarify the material foundation and action mechanism of RDS.

methodsTo conduct an analysis of RDS, an integrative analytical platform was constructed, including target prediction, protein-protein interaction (PPI) network, and cluster analysis; further, the hub genes involved in the disease-related pathways were identified, and the their corresponding compounds were used for in vitro validation of molecular docking predictions. The presence of these validated compounds was also measured in samples of the RDS formula to quantify the abundance of the biochemically active constituents. In our network pharmacological study, a total of 26 bioinformatic programs and databases were used, and six networks, covering the entire Zang-fu viscera, were constructed to comprehensively analyze the intricate connections among the compounds-targets-disease pathways-meridians of RDS.

resultsFor all 1071 known chemical constituents of the nine ingredients in RDS, identified from established TCM databases, 157 passed drug-likeness screening and led to 339 predicted targets in the constituent-target network. Forty-two hub genes with core regulatory effects were extracted from the PPI network, and 134 compounds and 29 crucial disease pathways were implicated in the target-constituent-disease network. Twelve disease pathways attributed to the Lung-Large Intestine meridians, with six and five attributed to the Kidney-Urinary Bladder and Stomach-Spleen meridians, respectively. One-hundred and eighteen candidate constituents showed a high binding affinity with SARS-coronavirus-2 3-chymotrypsin-like protease (3CL

conclusionRDS acts primarily in the Lung-Large Intestine, Kidney-Urinary Bladder and Stomach-Spleen meridians, with other Zang-fu viscera strategically covered by all nine ingredients. In the context of TCM meridian theory, the multiple components and targets of RDS contribute to RDS's dual effects of health-strengthening and pathogen-eliminating. This results in general therapeutic effects for early COVID-19 control and prevention.

Indexed as

Medicine, Chinese TraditionalMolecular Docking SimulationAntiviral AgentsBetacoronavirusCoronavirus 3C ProteasesCoronavirus InfectionsCOVID-19Cysteine EndopeptidasesDrugs, Chinese HerbalHumansMass SpectrometryPandemicsPneumonia, ViralProtein Interaction MapsSARS-CoV-2Viral Nonstructural ProteinsAntiviral AgentsCoronavirus 3C ProteasesCysteine EndopeptidasesDrugs, Chinese HerbalViral Nonstructural Proteins3C-like proteaseCOVID-19Lung-toxin Dispelling Formula No. 1Meridian tropismMolecular dockingNetwork pharmacology

Identifiers

PMID32307268
PMCPMC7195604
OpenAlexW3015271526

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.